Carasent ASA

CARA · Nasdaq Stockholm · Healthcare

26.00SEK 0.0%last day

Price as of 2 October 2026

The price over the past year, with dividends: −3.0%

Performance

1 month

−1.5%

1 year

−3.0%

3 years, per year

–

5 years, per year

–

Largest fall, 3 years

−76.9%

Below the peak now

−39.3%

Volatility, 1 year

31.3%

Return with dividends reinvested.

Key figures

P/E

42.6

P/B

2.3

Dividend yield

0.0%

Return on equity

+5.5%

Net margin

+11.9%

Market value

191 m USD

Quality, value and trend

Where Carasent stands against every Nordic stock today. 100 is best.

Quality67

Profitability and a sound balance sheet over time. Better than 67% of Nordic stocks.

Value27

The price measured against earnings, assets and cash flow. Better than 27% of Nordic stocks.

Trend71

The price development over the past year. Better than 71% of Nordic stocks.

Combined56

Quality, value and trend together. Better than 56% of Nordic stocks.

About Carasent

Carasent ASA is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 240 employees.

Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient communication and business intelligence. The company was founded in 1997 and is headquartered in Gothenburg, Sweden.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis